Piramal Pharma Limited (PPLPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Piramal Pharma Limited (NSE: PPLPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400. As of 21 Sep 2026, the share price was ₹208.00, market capitalisation ₹27,713 Cr, ROE -3.83%.
Get the AI verdict on PPLPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
PPLPHARMA price and valuation
- Share price
- ₹208.00
- Market cap
- ₹27,713 Cr
- P/E ratio
- -
- P/B ratio
- 3.39
- EPS
- ₹-2.36
- Book value per share
- ₹61.40
- Dividend yield
- 0.07%
PPLPHARMA profitability and growth
- ROE
- -3.83%
- ROCE
- 2.52%
- Debt to equity
- 0.7
- Revenue growth (3 yr)
- 8%
- Revenue growth (5 yr)
- 7%
- Profit growth (3 yr)
- -31%
- Profit growth (5 yr)
- -
PPLPHARMA 52-week range
- 52-week high
- ₹231.93
- 52-week low
- ₹132.30
- Face value
- ₹10.00
PPLPHARMA shareholding pattern
- Promoters
- 34.8%
- FIIs
- 12.51%
- DIIs
- 14.57%
- Public
- 37.62%
Index membership: NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.